The Indian hockey team continued its domination of arch-foes Pakistan, handing them a 6-1 thrashing in a 5th-8th place classification match of the Hero Hockey World League Semifinals today (24).
Goals by Ramandeep Singh (8', 28'), Talwinder Singh (25'), Mandeep Singh (27', 59'), and Harmanpreet Singh (36') helped India decimate Pakistan and set up a clash with Canada in the 5th-6th pace playoff.
The result dented Pakistan's hopes of booking a berth to participate at the Hockey World Cup to be held in Bhubaneswar next year.
India displayed good attack right from the start with their first real shot on goal coming as early as the opening minute when Ramandeep Singh set up one for an unmarked Akashdeep Singh in the circle.
But Akashdeep could not make a powerful connection to put the ball past Pakistan goalkeeper Amjad Ali.
Mandeep, meanwhile, helped India win their first Penalty Corner in the sixth minute but Harmanpreet Singh's flick was defended well by Pakistan.
Soon after, India were seen putting pressure on Pakistan, interrupting their counter-attack cornering Pakistan player with a three-man defence.
The strategy worked, with Pakistan losing the possession.
Satbir Singh, playing his 50th international match, was quick to spot Ramandeep in the circle who seized the opportunity for India to take a 1-0 lead in the 8th minute.
India took their lead to a convincing 4-0 in the second quarter.
First it was Pardeep Mor who did well with a fierce pass to Talwinder Singh who simply had to angle his stick to beautifully deflect the ball into the post in the 25th minute.
Brilliantly assisted by SV Sunil, Akashdeep, who had missed a golden opportunity early on, was exceptional with his dribble in the baseline to get past the defender to nick the ball towards the net.
It was Mandeep Singh who got the touch on the ball before it beat the keeper to take India's lead to a healthy 3-0 in the 27th minute.
India's fourth goal came in the 28th minute when Sunil assisted Ramandeep from the far post. It was a diving effort by Ramandeep that ensured he scored his second goal of the match.
Pressure mounted on Pakistan when India won their second PC in the 36th minute. Harmanpreet Singh made use of the opportunity as he came up with an improvised drag-flick, kept the ball low to beat the Pakistani keeper and take India's lead to a formidable 5-0.
Pakistan finally found a breakthrough in the 41st minute when Ajaz Ahmad took advantage of a defensive error on India's part to put the ball past keeper Vikas Dahiya.
The final quarter saw Pakistan make some desperate attempts on goal but India did well to contain their opponents with good defence.
With less than six minutes for the final hooter, Talwinder Singh swiftly dribbling into the striking circle did well to find his man Ramandeep on the far post who made a rapid attempt on goal.
But Pakistani defender Rizwan Jr. Muhammad was impeccable in his effort to deny Ramandeep his third goal of the match.
Mandeep Singh managed to take India's lead to 6-1 in the 59th minute scoring the goal off a rebound.
India won a PC in the dying seconds of the match when Pakistan defender fouled in the circle through a stick tackle but Harmanpreet's effort was defended well and India walked away with a comfortable 6-1 win.
UK life sciences sector contributed £17.6bn GVA in 2021 and supports 126,000 high-skilled jobs.
Inward life sciences FDI fell by 58 per cent from £1,897m in 2021 to £795m in 2023.
Experts warn NHS underinvestment and NICE pricing rules are deterring innovation and patient access.
Investment gap
Britain is seeking to attract new pharmaceutical investment as part of its plan to strengthen the life sciences sector, Chancellor Rachel Reeves said during meetings in Washington this week. “We do need to make sure that we are an attractive place for pharmaceuticals, and that includes on pricing, but in return for that, we want to see more investment flow to Britain,” Reeves told reporters.
Recent ABPI report, ‘Creating the conditions for investment and growth’, The UK’s pharmaceutical industry is integral to both the country’s health and growth missions, contributing £17.6 billion in direct gross value added (GVA) annually and supporting 126,000 high-skilled jobs across the nation. It also invests more in research and development (R&D) than any other sector. Yet inward life sciences foreign direct investment (FDI) fell by 58per cent, from £1,897 million in 2021 to £795 million in 2023, while pharmaceutical R&D investment in the UK lagged behind global growth trends, costing an estimated £1.3 billion in lost investment in 2023 alone.
Richard Torbett, ABPI Chief Executive, noted “The UK can lead globally in medicines and vaccines, unlocking billions in R&D investment and improving patient access but only if barriers are removed and innovation rewarded.”
The UK invests just 9% of healthcare spending in medicines, compared with 17% in Spain, and only 37% of new medicines are made fully available for their licensed indications, compared to 90% in Germany.
Expert reviews
Shailesh Solanki, executive editor of Pharmacy Business, pointed that “The government’s own review shows the sector is underfunded by about £2 billion per year. To make transformation a reality, this gap must be closed with clear plans for investment in people, premises and technology.”
The National Institute for Health and Care Excellence (NICE) cost-effectiveness threshold £20,000 to £30,000 per Quality-Adjusted Life Year (QALY) — has remained unchanged for over two decades, delaying or deterring new medicine launches. Raising it is viewed as vital to attracting foreign investment, expanding patient access, and maintaining the UK’s global standing in life sciences.
Guy Oliver, General Manager for Bristol Myers Squibb UK and Ireland, noted that " the current VPAG rate is leaving UK patients behind other countries, forcing cuts to NHS partnerships, clinical trials, and workforce despite government growth ambitions".
Reeves’ push for reform, supported by the ABPI’s Competitiveness Framework, underlines Britain’s intent to stay a leading hub for pharmaceutical innovation while ensuring NHS patients will gain faster access to new treatments.
By clicking the 'Subscribe’, you agree to receive our newsletter, marketing communications and industry
partners/sponsors sharing promotional product information via email and print communication from Garavi Gujarat
Publications Ltd and subsidiaries. You have the right to withdraw your consent at any time by clicking the
unsubscribe link in our emails. We will use your email address to personalize our communications and send you
relevant offers. Your data will be stored up to 30 days after unsubscribing.
Contact us at data@amg.biz to see how we manage and store your data.